HuGE Literature Finder
Records
1
-
30
| The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases. Annals of human genetics 2022 Dec . Cine Naci, Ugurtas Cansu, Gokbayrak Merve, Aydin Duygu, Demir Gulhan, Kuru Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Simsek Turgay, Cabuk Devrim, Aksu Maksut Gorkem, Canturk Nuh Zafer, Savli Hak |
| Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with TKIs: An updated systematic review and meta-analysis. Oncology letters 2022 Nov 24 (5): 384. Lan Bo, Zhao Na, Du Kang, Leng Baola |
| Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer. International journal of cancer 2022 Oct . Ma Yueyun, Li Wenjie, Chen Shiyu, Lin Shuimiao, Ding Sijie, Zhou Xiaomei, Liu Tongxin, Wang Rong, Wang W |
| Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer. Oncology 2022 Oct . Kim Hyera, Kim Jin Young, Park Keon |
| Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract. Cancer communications (London, England) 2022 Oct . Wu Huanwen, Yu Zicheng, Liu Yueping, Guo Lei, Teng Lianghong, Guo Lingchuan, Liang Li, Wang Jing, Gao Jie, Li Ruiyu, Yang Ling, Nie Xiu, Su Dan, Liang Zhiyo |
| Immunotherapy combined with chemotherapy improved clinical outcomes over bevacizumab combined with chemotherapy as first-line therapy in adenocarcinoma patients. Cancer medicine 2022 Oct . Wang Min, Li Ji, Xu Shuhui, Li Yuying, Li Jiatong, Yu Jinming, Tang Xiaoyong, Zhu H |
| Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia. Cancer 2022 Oct . Ye Matthew T, Wang Yi, Zuo Zhuang, Calin Steliana, He Hua, Tang Zhenya, Jabbour Elias J, Borthakur Gautam, Zhang Yizhuo, Yang Yaling, You M Jam |
| Molecular phenotyping of malignant canine mammary tumours: Detection of high-risk group and its relationship with clinicomolecular characteristics. Veterinary and comparative oncology 2022 Oct . Zamani-Ahmadmahmudi Mohamad, Jajarmi Maziar, Talebipour Saeed |
| PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study. BMC cancer 2022 Oct 22 (1): 1066. Kojima Kensuke, Imai Saki, Samejima Hironobu, Fujiwara Ayako, Tokunaga Toshiteru, Yoon Hyungeun, Okishio Kyoic |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS open bio 2022 Oct . Xu Fei, Cui Wen-Qiang, Liu Cun, Feng Fubin, Liu Ruijuan, Zhang Jingtao, Sun Chang-Ga |
| Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort. Lung cancer (Amsterdam, Netherlands) 2022 Oct 174 27-35. Bubendorf Lukas, Zoche Martin, Dafni Urania, Rüschoff Jan Hendrik, Prince Spasenija Savic, Marti Nesa, Stavrou Androniki, Kammler Roswitha, Finn Stephen P, Moch Holger, Peters Solange, Stahel Rolf |
| Analysis of the Relationship between Bladder Cancer Gene Mutation and Clinical Prognosis by High-Throughput Sequencing. Laboratory medicine 2022 Sep . Li Xiaohang, Liu Jie, Li An'an, Liu Xin, Miao Yuesong, Wang Zhiyo |
| Druggable gene alterations in Japanese patients with rare malignancy. Neoplasia (New York, N.Y.) 2022 Sep 33 100834. Ohmoto Akihiro, Hayashi Naomi, Fukada Ippei, Yamazaki Masumi, Yunokawa Mayu, Kasuga Akiyoshi, Shinozaki Eiji, Ueki Arisa, Tonooka Akiko, Takeuchi Kengo, Mori Seiichi, Kiyotani Kazuma, Takahashi Shun |
| Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I. Cancer 2022 Sep . Pang Lan-Lan, Gan Jia-Di, Tan Jia-Rong, Huang Yi-Hua, Liao Jun, Liang Wei-Ting, Deng Peng-Bo, Fang Wen-Fe |
| Fibroblast subsets in non-small cell lung cancer: associations with survival, mutations, and immune features. Journal of the National Cancer Institute 2022 Sep . Pellinen Teijo, Paavolainen Lassi, Martín-Bernabé Alfonso, Papatella Araujo Renata, Strell Carina, Mezheyeuski Artur, Backman Max, La Fleur Linnea, Brück Oscar, Sjölund Jonas, Holmberg Erik, Välimäki Katja, Brunnström Hans, Botling Johan, Moreno-Ruiz Pablo, Kallioniemi Olli, Micke Patrick, Östman Ar |
| Genomic landscape of pleural and peritoneal mesothelioma tumours. British journal of cancer 2022 Sep . Hiltbrunner Stefanie, Fleischmann Zoe, Sokol Ethan S, Zoche Martin, Felley-Bosco Emanuela, Curioni-Fontecedro Alessand |
| RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer. Journal of translational medicine 2022 Sep 20 (1): 390. Wang Chunyue, Zhang Zhenlong, Sun Yulan, Wang Song, Wu Mengmeng, Ou Qiuxiang, Xu Yang, Chen Zhiming, Shao Yang, Liu Hong, Hou Peife |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
| Four-copy number alteration (CNA)-related lncRNA prognostic signature for liver cancer. Scientific reports 2022 Aug 12 (1): 14261. Cheng Zhenyun, Guo Yan, Sun Jingjing, Zheng L |
| Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens. Urologic oncology 2022 Aug . Papadopoulou Kyriaki, Koliou Georgia-Angeliki, Tsimiliotis Dimitrios, Kotoula Vassiliki, Foukas Periklis, Goussia Anna, Tsiatas Marinos, Visvikis Anastasios, Chatzopoulos Kyriakos, Nifora Martha, Charchanti Antonia, Koumarianou Anna, Christodoulou Christos, Pectasides Dimitrios, Psyrri Amanda, Fostira Florentia, Fountzilas George, Samantas Epaminont |
| Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics. Diagnostics (Basel, Switzerland) 2022 Aug 12 (8): . Roma Cristin, Sacco Alessandra, Forgione Laura, Esposito Abate Riziero, Lambiase Matilde, Dotolo Serena, Maiello Monica Rosaria, Frezzetti Daniela, Nasti Guglielmo, Morabito Alessandro, De Luca Antonella, Normanno Nico |
| Prognostic of recurrence and survival in poorly differentiated thyroid cancer. Endocrine-related cancer 2022 Aug . Hescot Segolene, Al Ghuzlan Abir, Henry Theophraste, Sheikh Alard Hala, Lamartina Livia, Borget Isabelle, Hadoux Julien, Baudin Eric, Dupuy Corinne, Nikitski Alyaksandr V, Nikiforov Yuri E, Schlumberger Martin, Nikiforova Marina N, Leboulleux Soph |
| Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer. British journal of cancer 2022 Aug . Kimura Hiroko, Mizuno Kei, Shiota Masaki, Narita Shintaro, Terada Naoki, Fujimoto Naohiro, Ogura Keiji, Hatano Shotaro, Iwasaki Yusuke, Hakozaki Nozomi, Ishitoya Satoshi, Sumiyoshi Takayuki, Goto Takayuki, Kobayashi Takashi, Nakagawa Hidewaki, Kamoto Toshiyuki, Eto Masatoshi, Habuchi Tomonori, Ogawa Osamu, Momozawa Yukihide, Akamatsu Shusu |
| Tumor mutational burden and efficacy of chemotherapy in lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022 Aug . Song Juan, Yan Yu, Chen Cuicui, Li Jiamin, Ding Ning, Xu Nuo, Bao Hairong, Zhang Xin, Hong Qunying, Zhou Jian, Shao Yang W, Song Yuanlin, Tong Lin, Hu J |
| Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review. Frontiers in oncology 2022 12 973077. Yu Meijia, Zhang Qin, Zhao X |
| Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer. Frontiers in oncology 2022 12 957404. Zhou Jie, Lai Yiming, Peng Shengmeng, Tang Chen, Chen Yongming, Li Lingfeng, Huang Hai, Guo Zhengh |
| Genomic alterations predictive of poor clinical outcomes in pan-cancer. Oncotarget 2022 13 1069-1077. Seldon Crystal S, Meiyappan Karthik, Hoffman Hannah, Guo Jimmy A, Goel Neha, Hwang William L, Nguyen Paul L, Mahal Brandon A, Alshalalfa Mohamm |
| Integrative Analysis Reveals a Nine TP53 Pathway-Related lncRNA Prognostic Signature in Endometrial Cancer. BioMed research international 2022 2022 5432806. Wang Ying, Qu Xiaoling, Li Lisha, He De |
| Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors. Frontiers in oncology 2022 10 12 986674. Guan Yin, Wang Yutong, Li Hongxia, Meng Jing, You Xia, Zhu Xiaofeng, Zhang Qin, Sun Tingting, Qi Chuang, An Guangyu, Fan Ying, Xu Bing |
| The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies. Frontiers in immunology 2022 10 13 1009634. Chen Lei, Zheng Yi, Jiang Changqin, Yang Cheng, Zhang Li, Liang Chaozh |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: